Tag: Drug Safety
FDA Sends 100 Cease-and-Desist Letters in Crackdown on DTC Drug Advertisements
Additionally, the agency is eliminating the 'adequate provision' loophole that allowed pharmaceutical companies to list complete risks separately
FDA Creates ‘Green List’ of GLP-1 Drug Ingredients Approved for Entry in the U.S.
The purpose of the list is to keep unverified and unapproved GLP-1 drug ingredients from entering the country
Benefits of Long-Term Routine Lab Drug Toxicity Monitoring Unclear in RA
New very abnormal results mostly occur after DMARD dose increase, often already known or suspected
FDA Requiring Stronger Safety Labels for Opioid Medications
Updated opioid safety labeling is based on new data from two large postmarketing observational studies
Antiseizure Meds With Known or Uncertain Risks Continue to Be Prescribed in Pregnancy
However, safer antiseizure medications are gaining favor
Study Compares Benefits, Harms of Treatments for Chronic Hives
Systematic review and network meta-analysis included 93 trials evaluating 42 interventions
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research
Tidmarsh's areas of expertise include pediatrics, pediatric oncology, and neonatology
Medetomidine, a Pet Sedative, Spreads in U.S. Illegal Drug Supply
FDA and Novo Nordisk Alert Consumers to Counterfeit Ozempic
Pharmaceutical company and federal agency warn consumers not to use the counterfeit medication
FDA Announces Plan to Phase Out Some Animal Testing
New strategy aims to enhance drug safety, expedite evaluation process, and decrease animal experimentation
